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Abstract We had earlier reported the derivation and
characterization of two new sibling human embryonic stem
cell lines BJNhem19 and BJNhem20, from discarded grade
III embryos of Indian origin. We report here the character-
istics of the two sibling cell lines after long-term
continuous culture for over 2 yr during which they have
been passaged over 200 times. We show that both cell lines
adapt well to culture on various mouse and human feeders
as well as in feeder-free conditions. The cells show normal
diploid karyotype and continue to express all pluripotency
markers. Both cell lines differentiate to derivatives of all
three germ layers in vitro. However as reported earlier,
BJNhem19 is unable to generate teratomas in nude or
SCID mice or differentiate to beating cardiomyocytes when
tested over several passages during long-term stable
culture. On the other hand, the cardiac differentiation
capacity of BJNhem20 is greatly increased, and it can
generate beating cardiomyocytes that proliferate when
isolated and cultured further. In conclusion, the two cell
lines have maintained a stable phenotype for over 2 yr and
are indeed immortal. Their derivation from grade III
embryos does not seem to have any adverse effect on their
long-term phenotype. The cells can be obtained for research
purposes from the UK Stem Cell Bank and from the authors.
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Introduction
Human embryonic stem (hES) cells potentially provide an
unlimited resource for regenerative medicine. Since the
isolation of the first hES cell lines over 10 yr ago (Thomson
et al. 1998), several groups have successfully derived hES
cell lines using various techniques and from various genetic
backgrounds (http://www.stemcellforum.org/isci_project/
the_registry.cfm; http://www.mrc.ac.uk/Utilities/Document
record/index.htm?d=MRC003259; http://stemcells.nih.gov/
research/registry/). The common theme in these has been
the demonstration that hES cell lines can maintain their
pluripotent characteristics in culture and can differentiate to
derivatives of all three germ layers. It is generally
acknowledged that hES cell lines derived from different
genetic backgrounds differ in their characteristics and
behavior (Enver et al. 2005) yet express common markers
of pluripotency (Adewumi et al. 2007). However, little
information exists about the effects of long-term culture on
most hES cell lines in use. A couple of studies encourag-
ingly showed that a set of cell lines in continuous culture
for over a year maintained a stable phenotype (Rosler et al.
2004; Suemori et al. 2006). It is hoped that these features
will be common to all hES cell lines derived thus far, as
scale-up and long-term culture of hES cells under defined
conditions will be essential for their therapeutic application.
If this is not a dependable property of hES cells regardless
of genetic background, then it limits their potential
applications in therapy. We earlier reported derivation and
characterization of two sibling hES cell lines BJNhem19
and BJNhem20, from India (Inamdar et al. 2009). We
report here a preliminary characterization of their stability
and pluripotency after long-term culture.
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hES cell culture and differentiation. Stocks for long-term
culture were maintained in antibiotic-free media on mouse
embryonic fibroblasts (MEFs) and were passaged mechan-
ically. Culture of hES cells on MEFs and differentiation to
embryoid bodies was as described earlier (Inamdar et al.
2009). For culture on human feeders, human foreskin
fibroblasts (HFF; ATCC cat. no. SCRC1041) were mitot-
ically inactivated by gamma irradiation (60 Gy) and used as
for MEFs. Other substrates used were gelatin (0.1% in
phosphate buffered saline; Sigma cat. no. G1393), fibro-
nectin (5 μg/cm
2, Sigma Cat. no. F2518), or Matrigel
(1:100 dilution, Becton Dickinson cat. no. 354277). Culture
on gelatin or fibronectin was in hES media conditioned by
incubation for 24 h with mitotically inactivated MEFs.
Culture on Matrigel was in mTeSR1 media (Stem Cell
Technologies, Palo Alto, CA) according to the manufac-
turer’s instructions.
Characterization of hES cells. Karyotyping, reverse
transcription-polymerase chain reaction (RT-PCR) analysis,
and immunostaining for pluripotency markers were done as
described before (Inamdar et al. 2009). hES cells grown on
feeders or appropriate matrix were fixed in 2.5% paraformal-
dehyde in phosphate buffer solution and stained with
appropriate antibodies as described before (Siva et al. 2007).
Primary antibodies used were against SSEA4, TRA-1-60,
and TRA-1-81 (kind gift of Peter Andrews, Sheffield),
OCT4, VEGFRII, (BD Pharmingen, San Diego, CA),
vimentin, alpha-fetoprotein, α-actinin (Sigma Chemical
C o . ,S t .L o u i s ,M O ) ,B r a c h y u r y ,T b x - 5( S a n t aC r u z
Biotechnology, Santa Cruz, CA), and nestin (Chemicon,
Temecula, CA). Alexa Fluor-conjugated secondary anti-
bodies were from Molecular Probes, Eugene, OR.
Cardiomyocyte culture and proliferation. Undifferentiated
BJNhem20 colonies were removed manually and cultured
in 0.75% dimethyl sulfoxide (DMSO) embryoid body (EB)
media in a low attachment dish for 3 d as described before
(Inamdar et al. 2009). EBs were transferred to gelatin-
coated dishes on day 4 and fed with the same media for
10 d, after which, they were fed with normal EB media.
Beating areas were cut with finely pulled glass micro-
needles after day 2 of beating, dissociated in microdrops of
0.05% trypsin-EDTA, and plated at low cell density on
gelatin-coated dishes. Cultures were imaged each d in phase
contrast, fixed after 8 d, and immunostained with Tbx-5 or
α-actinin.
Teratoma analysis. Teratoma formation was tested in nude
(N) mice as well as SCID (S) mice. A total of eight mice
(4N+4S) for BJNhem19 and five mice (4N+1S) for
BJNhem20 were injected with about 10 million cells at
one subcutaneous site on the right flank. Teratomas were
obtained only with BJNhem20 in three nude mice.
Teratomas were excised after 8–10 wk, fixed, cryosec-
tioned, and stained with hematoxylin and eosin. Represen-
tative images are shown in Fig. 1S–U.
Results and Discussion
We previously reported culture of BJNhem19 and BJNhem20
on MEFs. These were derived from poor quality grade III
embryos generated during in vitro fertilization. Out of 21
discarded embryos obtained, one was lost during manipula-
tion, two were cultured whole (group A), and 18 were
subjected to immunosurgery (group B), of which, six were
further dissected to isolate the inner cell mass (ICM; subset
B1). Of 13 group B embryos that showed ICM-like out-
growths, five belonged to subset B1, of which, two sibling
embryos gave hES cell lines. This indicates that mechanical
dissection of the ICM greatly improved the success rate,
probably due to complete elimination of trophectoderm.
Hence, though the ICM is reduced or damaged in most
discarded embryos, the efficiency of hES cell derivation can
be greatly increased by isolating the ICM from the trophecto-
derm and dead cells.
We have since cultured the cells on MEFs derived from
CF-1 mouse strain and obtained from different sources
(ATCC, Chemicon, and derived in-house). The cells can be
cultured successfully on MEFs from all three sources (data
not shown). The density of MEFs consistently determined
the uniform appearance of colonies in culture from early to
late passages. For our hES cells, high density of MEFs
promotes differentiation, whereas very low densities of
MEFs are conducive to maintaining the undifferentiated
phenotype. Further, colony remnants left to re-grow in the
original dish grow better as there are almost no MEFs
adhering to the dish (Fig. 1A). The MEFs that are sloughed-
off during the course of culture may have laid down a
matrix that supports robust growth of pluripotent hES cells.
We also cultured the hES cells on HFF and in feeder-free
conditions on dishes coated with various substrates such as
gelatin, fibronectin, or Matrigel. HFF supported growth of
BJNhem19 and BJNhem20, but the colony morphology was
different from that on MEFs (Fig. 1B), while pluripotency
marker expression was normal (data not shown). Gelatin
did not support growth of the hES cells, whereas culture on
fibronectin supported growth of undifferentiated colonies
(Fig. 1C). BJNhem19 and BJNhem20 were also success-
fully cultured on Matrigel-coated tissue culture dishes for
over ten passages with defined media (Fig. 1D). No
adaptation was required for the cells. Such cultures could
be passaged mechanically as well as enzymatically without
LONG-TERM CULTURE OF HUMAN ES CELLS 201Figure. 1 Characterization of human embryonic stem (hES) cells. A–
P, Morphology and marker analysis of hES colonies on various
substrates. A–D, Phase contrast micrographs showing BJNhem20 cells
growing on (A) ultra-low mouse embryonic fibroblasts density in a
dish passaged by mechanical cutting and re-incubated for colony
fragments to re-grow (B) human foreskin fibroblasts, (C) fibronectin,
and (D)M a t r i g e l .E–L, Fluorescent immunostaining of (E–H)
BJNhem19 and (I–L) BJNhem20 cells grown on Matrigel and stained
with antibodies recognizing (E, I) OCT4 (green), (F, J) SSEA4
(green), (G, K) TRA-1-60 (red), and (H, L) TRA-1-81 (red). M–P,N o
primary antibody controls showing (M) green secondary and (N)
corresponding DAPI image and (O) red secondary and (P)
corresponding DAPI image. In (E–P), nuclei are blue (DAPI). Q–R,
Karyotype of (Q) BJNhem19 showing 46,XY and (R) BJNhem20
showing 46,XX chromosomes. S–U, Representative bright field
photomicrographs of H&E stained teratoma sections of BJNhem20
teratoma showing differentiation to (S) ectodermal, (T) mesodermal,
and (U) endodermal lineages. cg cartilage, epi epidermis, ge gut
epithelium, ne neural epithelium, nr neural rosette, sm smooth muscle.
Scale bar:( A) 200 μm, (B–P, U) 100 μm, (S)2 5μm, (T)5 0μm.
202 VENU ET AL.LONG-TERM CULTURE OF HUMAN ES CELLS 203any adverse effect. Cultures grown on Matrigel were stained
for pluripotency marker gene expression (Fig. 1E–P).
BJNhem19 and BJNhem20 showed maintenance of plurip-
otent characteristics on Matrigel in defined media.
Both BJNhem19 and BJNhem20 have now been in
continuous culture for 2 yr, and the stocks have been
passaged mechanically. BJNhem19 is at passage 212 and
BJNhem20 at passage 230, both showing normal diploid
karyotype (Fig 1Q, R). A difference of about 15–20
passages has been maintained consistently between the
two cell lines since around passage 15, as BJNhem19 was
initially slow growing. However, BJNhem19 cultures
showed marked improvement in colony morphology and
growth characteristics from about passage 80, suggesting
genetic or epigenetic adaptation to culture. The two cell
lines have been analyzed at multiple passages for karyotyp-
ing and for expression of pluripotency markers, and data for
the latest analysis are shown in Fig. 1Q, R and Fig. 2.R T -
PCR analysis shows expression of DNMT3B, GABRB3,
GDF3, OCT4, NANOG, SOX2, TERF1, TDGF, LEFTA,
THY1, REX1, and FGF4 (Fig. 2A, B). Interestingly FGF4
expression was not detected at early passages (Inamdar et
al. 2009) for both lines suggesting that this late expression
could be a result of adaptation to culture. Both BJNhem19
and BJNhem20 express OCT4, SSEA4, TRA1-60, and
TRA1-81 uniformly in all the colonies (Fig. 2C–J).
BJNhem19 and BJNhem20 cells are capable of differ-
entiating into derivatives of all three germ layers in vitro
even after long-term culture (Fig. 2K–T). Cultures were
stained at various days of differentiation as described before
(Inamdar et al. 2009) and showed cells expressing the
neuronal marker nestin (Fig. 2K, L), mesodermal markers
Brachyury (Fig. 2M, N) and vimentin (Fig. 2O, P),
endothelial marker VEGFRII (Fig. 2Q, R), and endodermal
marker alpha-fetoprotein (Fig. 2S,T). However, no beating
cardiomyocytes or teratomas were obtained from early or
late passage BJNhem19 cells indicating that adaptation had
not changed the differentiation capacity. BJNhem20 cells at
late passages could be differentiated to cardiomyocytes
spontaneously as well as with DMSO induction with a
higher efficiency than for early passages. While only 5% of
early passage (p) EBs showed spontaneous appearance of
beating cardiomyocytes, later passages had 45.5% (p101),
58.3% (p115), and 62.5% (p135) beating EBs. We also
tested whether the BJNhem20-derived cardiomyocytes
proliferated in culture. Beating areas were observed by
day 6 or 7 of differentiation as opposed to day 12 seen at
earlier passages. The early differentiation was first observed
at p91. Small groups of cells as well as isolated cells
showed beating within 24 h after dissociation by trypsin.
Cultures were monitored for 8 d for beating and prolifer-
ation by imaging in phase contrast (Fig. 3A–D, H–K)a s
well as counting DAPI-stained nuclei (not shown). Analysis
of two representative cultures is shown in Fig. 3. Cultures
Figure. 2 Analysis of pluripotency and differentiation marker gene
expression in BJNhem19 at p143 and BJNhem20 at p161. A–B,
Reverse transcription-polymerase chain reaction (RT-PCR) analysis of
undifferentiated BJNhem19 (A)a n dB J N h e m 2 0( B) cells. PCR
products were obtained using primers specific for FGF4, DNMT3B,
GABRB3, GDF3, OCT4, NANOG, SOX2, TERF1, TDGF, LEFTA,
THY1, and REX1 as indicated. M molecular weight marker. C–T,
Fluorescent immunostaining of undifferentiated (C–J) and differenti-
ated EBs (K–T) of BJNhem19 (C, E, G, I, K, M, O, Q, S) and
BJNhem20 (D, F, H, J, L, N, P, R, T) cells stained with antibodies
recognizing various markers as indicated. C, D OCT4 (green), (E, F)
SSEA4 (green), (G, H) Tra-1-60 (red), (I, J) Tra-1-81 (red), (K, L)
ectodermal (nestin), (M–R) mesodermal (Brachyury, vimentin, and
VEGFRII), and (S, T) endodermal (alpha-fetoprotein). In (C–X),
nuclei are blue (DAPI). U–X, No primary antibody controls showing
(U) green anti-mouse secondary and (V) corresponding DAPI image and
(W) red anti-mouse secondary and (P) red anti-rat secondary. Magnifi-
cation is same for (C–J, U, V)a n df o r( K–T, W, X). Scale bar: 100 μm.
Figure. 3 Analysis of contracting cells obtained from BJNhem20
human embryonic stem cells. Beating clumps from trypsinized EBs
were plated on gelatin and analyzed for proliferation and marker
expression. Two representative cell clusters are shown here. A–G cells
from EB1 imaged in (A–D) phase contrast at day 2 (A), day 4 (B),
day 6 (C), and day 8 (D) and (E–G) immunofluorescence to show
Tbx5 expression (green) at day 8. H–N cells from EB2 imaged in (H–
K) phase contrast at day 2 (H), day 4 (I), day 6 (J), and day 8 (K) and
(L–N) immunofluorescence to show α-actinin expression (red)a t
day 8. In (F, G, M, N), nuclei are in blue (DAPI). G, N show merged
images of marker and nuclear staining. Magnification is the same for
all images. Scale bar:5 0μm.
R
204 VENU ET AL.were also stained for the cardiac progenitor marker Tbx5
(Fig. 3E–G) and the cardiomyocyte marker α-actinin
(Fig. 3L–N). While only a subset of cultured cells expressed
Tbx5, all cells analyzed expressed α-actinin. These data
show that hES cell-derived cardiac cells can be isolated and
expanded in culture. Cultured cells showed increase in size
and number (Fig.3A–D, H–K).
In conclusion, our data support and add to previous
reports (Rosler et al. 2004; Suemori et al. 2006) indicating
that hES cells are indeed immortal and stable over long-
term culture. Also, hES cell lines derived from defective
embryos can be cultured long-term and can maintain their
diploid karyotype and pluripotent characteristics. Further,
this is the first report of long-term culture of genetically
related cell lines representing the Indian ethnic background.
Thus, the cell lines BJNhem19 and BJNhem20 can be used
reliably for studies on hES cell pluripotency and differenti-
ation as well as for various drug screens that require testing
on different genetic backgrounds. BJNhem20 is especially
suitable for studies on cardiomyocyte differentiation. The
two cell lines have also been deposited in the UK Stem Cell
Bank (http://www.ukstemcellbank.org.uk/accessioned.html;
UKSCBaccessionnos.R-08-021andR-08-022)andarelisted
on the European hESC Registry (http://www.hescreg.eu/).
Early passage stocks of the cells are also available for
distribution.
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